KIALY MUDD: Open Payments
NPI 1063015329 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 53 payments from 16 companies in 2025. Trend: 2023 $56 · 2024 $636 · 2025 $1,016
Food & beverage: $1,016
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $265 |
| Lilly USA, LLC | 8 | $166 |
| PFIZER INC. | 5 | $95 |
| Exact Sciences Corporation | 5 | $90 |
| Novo Nordisk Inc | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| Boston Scientific Corporation | 1 | $34 |
| GlaxoSmithKline, LLC. | 2 | $32 |
Products named: VRAYLAR, UBRELVY, Cologuard Collection Kit, MOUNJARO, ELIQUIS, QULIPTA, REXULTI, ZEPBOUND.
Industry payments across MO — which companies pay providers there.
